These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 21255816)

  • 21. Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans.
    Malafa S; Medits I; Aberle JH; Aberle SW; Haslwanter D; Tsouchnikas G; Wölfel S; Huber KL; Percivalle E; Cherpillod P; Thaler M; Roßbacher L; Kundi M; Heinz FX; Stiasny K
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008034. PubMed ID: 32017766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.
    de Alwis R; Williams KL; Schmid MA; Lai CY; Patel B; Smith SA; Crowe JE; Wang WK; Harris E; de Silva AM
    PLoS Pathog; 2014 Oct; 10(10):e1004386. PubMed ID: 25275316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Many Faces of a Dynamic Virion: Implications of Viral Breathing on Flavivirus Biology and Immunogenicity.
    Dowd KA; Pierson TC
    Annu Rev Virol; 2018 Sep; 5(1):185-207. PubMed ID: 30265634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4 T cell responses to flaviviruses.
    Aberle JH; Koblischke M; Stiasny K
    J Clin Virol; 2018 Nov; 108():126-131. PubMed ID: 30312909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flaviviruses and their antigenic structure.
    Heinz FX; Stiasny K
    J Clin Virol; 2012 Dec; 55(4):289-95. PubMed ID: 22999801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies.
    Contreras M; Stuart JB; Levoir LM; Belmont L; Goo L
    mBio; 2024 Feb; 15(2):e0304823. PubMed ID: 38193697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease.
    Pinto AK; Hassert M; Han X; Barker D; Carnelley T; Branche E; Steffen TL; Stone ET; Geerling E; Viramontes KM; Nykiforuk C; Toth D; Shresta S; Kodihalli S; Brien JD
    Front Immunol; 2021; 12():717425. PubMed ID: 34552587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human antibody response to dengue virus infection.
    Wahala WM; Silva AM
    Viruses; 2011 Dec; 3(12):2374-95. PubMed ID: 22355444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.
    Acosta EG; Bartenschlager R
    Expert Rev Vaccines; 2016; 15(4):467-82. PubMed ID: 26577689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.
    Mehlhop E; Nelson S; Jost CA; Gorlatov S; Johnson S; Fremont DH; Diamond MS; Pierson TC
    Cell Host Microbe; 2009 Oct; 6(4):381-91. PubMed ID: 19837377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
    Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
    J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Previous dengue or Zika virus exposure can drive to infection enhancement or neutralisation of other flaviviruses.
    Oliveira RA; de Oliveira-Filho EF; Fernandes AI; Brito CA; Marques ET; Tenório MC; Gil LH
    Mem Inst Oswaldo Cruz; 2019; 114():e190098. PubMed ID: 31411310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora's box?
    Gunawardana SA; Shaw RH
    BMC Infect Dis; 2018 Dec; 18(1):641. PubMed ID: 30526531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans.
    Burgomaster KE; Foreman BM; Aleshnick MA; Larman BC; Gordon DN; Maciejewski S; Morabito KM; Ledgerwood JE; Gaudinski MR; Chen GL; Mascola JR; Debbink K; Dowd KA; Graham BS; Pierson TC
    J Infect Dis; 2021 Nov; 224(9):1550-1555. PubMed ID: 33961055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural Basis of Zika Virus Specific Neutralization in Subsequent Flavivirus Infections.
    Sevvana M; Rogers TF; Miller AS; Long F; Klose T; Beutler N; Lai YC; Parren M; Walker LM; Buda G; Burton DR; Rossmann MG; Kuhn RJ
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33255202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous flavivirus infection-enhancing antibodies in sera of Nigerians.
    Fagbami A; Halstead SB; Marchette N; Larsen K
    Am J Trop Med Hyg; 1988 Jan; 38(1):205-7. PubMed ID: 2829637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.
    Cherrier MV; Kaufmann B; Nybakken GE; Lok SM; Warren JT; Chen BR; Nelson CA; Kostyuchenko VA; Holdaway HA; Chipman PR; Kuhn RJ; Diamond MS; Rossmann MG; Fremont DH
    EMBO J; 2009 Oct; 28(20):3269-76. PubMed ID: 19713934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques.
    McCracken MK; Gromowski GD; Friberg HL; Lin X; Abbink P; De La Barrera R; Eckles KH; Garver LS; Boyd M; Jetton D; Barouch DH; Wise MC; Lewis BS; Currier JR; Modjarrad K; Milazzo M; Liu M; Mullins AB; Putnak JR; Michael NL; Jarman RG; Thomas SJ
    PLoS Pathog; 2017 Aug; 13(8):e1006487. PubMed ID: 28771605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.